Founded in 1998 in Shanghai, MicroPort is a China-based global medical technology company dedicated to advancing healthcare innovation. It delivers cutting-edge solutions across cardiovascular, cerebrovascular, neurovascular, electrophysiology, orthopedics, urology, surgical robotics, and medical AI. With advanced R&D and manufacturing hubs in China, the USA, France, Germany, the UK, Italy, and the Dominican Republic, MicroPort operates an integrated industrial ecosystem that bridges innovation, supply chain efficiency, and market access.

Driven by a philosophy of mastering every detail, MicroPort collaborates closely with the medical community to ensure its products enhance patient outcomes. Listed on the Hong Kong Stock Exchange (00853.HK), it employs approximately 9,000 people and serves over 3,000 hospitals in more than 100 countries.